Feature | September 02, 2014

Study Confirms CT Lung Cancer Screening is Cost-Effective: Full Medicare Coverage Should Follow, Says ACR

September 2, 2014 — An actuarial cost-benefit analysis published in the August issue of American Health and Drug Benefits shows that use of U.S. Preventive Services Task Force (USPSTF) lung cancer screening recommendations in high-risk Medicare beneficiaries is cost-effective, potentially answering any questions regarding the effectiveness, infrastructure and cost effectiveness of low-dose computed tomography (CT) screening.

This latest analysis echoes a 2012 study published in Health Affairs that found low-dose CT lung cancer screening is cost-effective in high-risk, commercially insured people. National Lung Screening Trial (NLST) data presented to the National Institutes of Health (NIH) confirmed the test is cost effective — particularly compared to other screening programs. Other published data show the test is more cost-effective than automobile seatbelts/airbags.

“CT lung cancer screening is cost-effective and significantly reduces lung cancer deaths. Published results show no undue or lasting patient anxiety from the screening process. It is time for Medicare to cover CT lung cancer screening,” said Ella Kazerooni, M.D., FACR, chair of the American College of Radiology (ACR) Lung Cancer Screening Committee and ACR Thoracic Imaging Panel.

Significant lung cancer screening infrastructure is growing. The ACR Lung Cancer Screening Center program helps ensure these exams are provided safely and effectively. Lung-RADS standardizes CT lung cancer screening reporting and management, aids lung CT interpretation and supports outcomes monitoring.

The Affordable Care Act requires private insurers to cover medical procedures that receive a grade of “B” or higher from the USPSTF without a co-pay. The ACA does not specify that Medicare beneficiaries receive full coverage for these services. CT lung cancer screening is deemed an Essential Health Benefit, covered by many private health insurers, while Medicare beneficiaries have lesser access to these exams and increased risk of lung cancer death due to lack of coverage.

“Lung cancer is the nation’s leading cancer killer, annually taking more lives than breast, prostate and colon cancer combined. CT lung cancer screening could save up to 30,000 people each year. Medicare needs to help doctors save lives by fully covering these exams,” concluded Kazerooni.

For more information: www.acr.org

Related Content

Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | Computed Tomography (CT) | August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
The American Lung Association created LUNG FORCE, a national movement to defeat lung cancer
News | Lung Cancer | August 02, 2017
To raise public awareness of lung cancer—the leading cancer killer of men and women—the American Lung Association's...
GE’s DoseWatch is a digital informatics solution that automatically collects, monitors and reports on radiation dose indices for diagnostic imaging exams
News | Radiation Dose Management | July 31, 2017
GE Healthcare announced that it has licensed computed tomography (CT) organ dosimetry technology developed at Duke...
Contrast Media from Bayer, trends in contrast media and developments in contrast media
Feature | Contrast Media | July 28, 2017 | By Dave Fornell
Here are several updates in medical imaging ...
New York Hospital Finds Significant Cost Savings With Toshiba’s Aquilion One CT
News | Computed Tomography (CT) | July 25, 2017
In five years, Kaleida Health’s Stroke Care Center (SCC) at the Gates Vascular Institute in Buffalo, N.Y., has realized...
Samsung Introduces FDA-Cleared BodyTom Elite CT Scanner
Technology | Computed Tomography (CT) | July 24, 2017
Samsung announced U.S. Food and Drug Administration (FDA) approval of the BodyTom Elite, an upgraded version of its...
Sponsored Content | Videos | CT Angiography (CTA) | July 21, 2017
DAIC and ITN Editor Dave Fornell discusses some of the most innovative new computed tomography (CT) technology and tr
ACR Updates Radiation Oncology and Medical Physics Guidance With ASTRO and AAPM
News | Radiation Dose Management | July 19, 2017
July 19, 2017 — The American College of Radiology (ACR) recently collaborated with professional medical societies to
Sponsored Content | Videos | CT Angiography (CTA) | July 19, 2017
Matthew Budoff, M.D., FACC, professor of medicine, David Geffen School of Medicine at UCLA, endowed chair of preventi
Overlay Init